Evove
Develops precision-engineered filtration and separation membranes using additive manufacturing and graphene-based coatings.
- CEO / Founder
- Chris Wyres
- Team Size
- 11-50
- Stage
- Growth Stage
- Total Funding
- $22.6M
- Latest Round
- Strategic Investment - Undisclosed - October 2025
- Key Investors
- At One Ventures; AM Ventures; NPIF – Maven Equity Finance; Maven Capital Partners; Northern Powerhouse Investment Fund; One Small Planet; Kurita Water Industries
Technology & Products
Key Products
Enhance (enhanced membranes); Separonics (precision-engineered ceramic membranes)
Technological Advantage
Proprietary Separonics architecture enables higher throughput and selectivity; utilizes Lithoz LCM technology for high-precision ceramic manufacturing.
Differentiation
Value Proposition
Provides transformational productivity gains in selectivity and flux while reducing energy consumption and equipment lifetime compared to conventional membrane processes.
How They Differentiate
Unlike conventional membranes, Evove's AM-enabled Separonics membranes offer superior flux and selectivity through precise pore control and graphene integration.
Market & Competition
Target Customers
Lithium extraction companies, desalination plants, food and beverage manufacturers, industrial wastewater treatment facilities
Industry Verticals
Mining (Lithium/Vanadium extraction); Water Treatment; Desalination; Food & Beverage; Industrial Wastewater
Competitors
Traditional membrane manufacturers (e.g., DuPont, Suez/Veolia)
Growth & Milestones
Growth Metrics
Completed £5.7M funding round to accelerate growth; achieved 92% lithium recovery and 96.5% purity in demonstration trials
Major Milestones
Rebranded from G2O Water Technologies to Evove; Signed MOU with Saline Water Conversion Corporation for industrial desalination trials; Partnered with Northern Lithium for UK's first commercial-scale DLE plant
Notable Customers
Saline Water Conversion Corporation; Northern Lithium; Zelandez